[Oxaliplatin]

Suppl Tumori. 2004 Jul-Aug;3(4):S111-2.
[Article in Italian]
No abstract available

Publication types

  • Review

MeSH terms

  • Administration, Oral
  • Antineoplastic Agents / adverse effects
  • Antineoplastic Agents / therapeutic use*
  • Antineoplastic Agents, Phytogenic / administration & dosage
  • Antineoplastic Agents, Phytogenic / therapeutic use*
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / drug therapy
  • Carcinoma, Non-Small-Cell Lung / drug therapy
  • Colorectal Neoplasms / drug therapy*
  • Fluorouracil / administration & dosage
  • Humans
  • Leucovorin / administration & dosage
  • Lung Neoplasms / drug therapy
  • Nervous System Diseases / chemically induced
  • Organoplatinum Compounds / administration & dosage
  • Organoplatinum Compounds / adverse effects
  • Organoplatinum Compounds / therapeutic use*
  • Oxaliplatin
  • Vinblastine / administration & dosage
  • Vinblastine / analogs & derivatives*
  • Vinblastine / therapeutic use*
  • Vinorelbine

Substances

  • Antineoplastic Agents
  • Antineoplastic Agents, Phytogenic
  • Organoplatinum Compounds
  • Oxaliplatin
  • Vinblastine
  • Leucovorin
  • Vinorelbine
  • Fluorouracil